Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6170
Revolutionary Stroke Recovery - How Umbilical Cord Blood is Changing the Game - Cord Blood

Cord Blood

and Stem Cell Banking

Revolutionary Stroke Recovery – How Umbilical Cord Blood is Changing the Game

Cell cross section

A new approach has emerged for the treatment of cerebrovascular disorders such as stroke. This innovative method involves the use of umbilical cord blood (UCB), a source rich in regenerative cells, which has shown promising results in repairing brain damage caused by strokes.

Why Umbilical Cord Blood?

Umbilical cord blood is not just any blood. It’s a treasure trove of hematopoietic (blood-forming) and mesenchymal stem/progenitor cells that have the remarkable ability to proliferate and repair. These cells have been compared with those found in bone marrow and adult peripheral blood, and the results are clear: UCB cells are superior in their capacity to regenerate. One of the key advantages of using UCB cells for therapy is their low likelihood of causing an immune response in the recipient, making them safer and more effective than other cell sources.

Additionally, collecting UCB is a low-risk procedure for the donor, and the cells can be cryopreserved—frozen for future use—with high standards of quality control. This ease of collection and storage makes UCB an accessible and valuable resource for regenerative medicine.

The Power of UCB in Stroke Recovery

Stroke often leads to significant physical and cognitive impairments due to the brain damage it causes. However, studies have shown that intravenous administration of UCB-derived CD34+ cells (a type of stem cell found in UCB) can significantly improve recovery in animals that have suffered a stroke. These animals not only showed restoration of physical and cognitive functions but also exhibited a remarkable recovery in brain volume at the site of injury. This breakthrough suggests that UCB could hold the key to enhancing the repair process in stroke-damaged brains.

Addressing a Critical Question

Despite these exciting advancements, a critical question remained unanswered: How exactly do UCB-derived CD34+ cells facilitate tissue regeneration? Recent research aimed to tackle this question by looking at whether these cells need to maintain their ability to proliferate in order to repair tissue. Interestingly, it was found that even when these cells were subjected to X-irradiation—a process that eliminates their proliferative capability to ensure immunological safety—they retained their regenerative effects. This discovery is pivotal, as it implies that UCB cells can be used safely in patients without the risk of graft-versus-host disease (GVHD) or tumor formation, concerns that have previously limited the use of regenerative cell therapies.

A Paradigm Shift in Regenerative Therapy

The implications of this research are profound. It not only provides insight into the mechanism of tissue repair by stem/progenitor cells in UCB but also opens up new avenues for regenerative therapy. By demonstrating that UCB cells can exert their healing effects without the need for cell proliferation, this study paves the way for safer and potentially more effective treatments for stroke and other cerebrovascular disorders.